2007Unpublished venueRequires access

Expression of the urokinase-type plasminogen activator is associated with epithelial ovarian carcinoma

Gaopi Deng

Open publisher page 0 citations

Abstract

Objective: To identify the significance of urokinase-type plasminogen activator(UPA) expression in patients with epithelial ovarian carcinoma.Methods: UPA expression was measured by immunohistochemical staining in 15 normal ovary,15 benign ovarian tumor and 89 epithelial ovarian carcinoma.Results: UPA was negative in all 15 normal ovary and 14 in 15 benign ovarian tumor.The positive rate of UPA was 59.55% in ovarian carcinoma.The UPA positive rates in Stage(Ⅰ+Ⅱ) and Stage(Ⅲ+Ⅳ) were 41% and 74%,and it was significantly higher in advanced stages.The UPA expression was associated with the tumor grades,its positive rates were 25% in grade 1,59.8% in grade 2 and 80% in grade 3.The UPA positive rate in primary ovarian carcinoma was lower than in metastatic tumor,(64.2% vs 84.2%).Conclusion: The UPA expression can help to judge whether a ovarian tumor is benign or malignant.The UPA expression was significantly associated with the invading and metastasis of epithelial ovarian carcinoma.

About this research paper

What this paper is about

Objective: To identify the significance of urokinase-type plasminogen activator(UPA) expression in patients with epithelial ovarian carcinoma.Methods: UPA expression was measured by immunohistochemical staining in 15 normal ovary,15 benign ovarian tumor and 89 epithelial ovarian carcinoma.Results: UPA was negative in all 15 normal ovary and 14 in 15 benign ovarian tumor.The positive rate of UPA was 59.55% in ovarian carcinoma.The UPA positive rates in Stage(Ⅰ+Ⅱ) and Stage(Ⅲ+Ⅳ) were 41% and 74%,and it was significantly higher in advanced stages.The UPA expression was associated with the tumor grades,its positive rates were 25% in grade 1,59.8% in grade 2 and 80% in grade 3.The UPA positive rate in primary ovarian carcinoma was lower than in metastatic tumor,(64.2% vs 84.2%).Conclusion: The UPA expression can help to judge whether a ovarian tumor is benign or malignant.The UPA expression was significantly associated with the invading and metastasis of epithelial ovarian carcinoma.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To identify the significance of urokinase-type plasminogen activator(UPA) expression in patients with epithelial ovarian carcinoma.Methods: UPA expression was measured by immunohistochemical staining in 15 normal ovary,15 benign ovarian tumor and 89 epithelial ovarian carcinoma.Results: UPA was negative in all 15 normal ovary and 14 in 15 benign ovarian tumor.The positive rate of UPA was 59.55% in ovarian carcinoma.The UPA positive rates in Stage(Ⅰ+Ⅱ) and Stage(Ⅲ+Ⅳ) were 41% and 74%,and it was significantly higher in advanced stages.The UPA expression was associated with the tumor grades,its positive rates were 25% in grade 1,59.8% in grade 2 and 80% in grade 3.The UPA positive rate in primary ovarian carcinoma was lower than in metastatic tumor,(64.2% vs 84.2%).Conclusion: The UPA expression can help to judge whether a ovarian tumor is benign or malignant.The UPA expression was significantly associated with the invading and metastasis of epithelial ovarian carcinoma.

Key concepts: Plasminogen activator, Ovarian carcinoma, Immunohistochemistry, Urokinase, Ovarian tumor, Metastasis, Ovary, Carcinoma

Related papers

Back to paper searchBrowse research topicsOriginal source
Expression of the urokinase-type plasminogen activator is associated with epithelial ovarian carcinoma — Research Paper | ScholarLens